Viberzi and Bentyl drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Viberzi (eluxadoline) and Bentyl (dicyclomine hydrochloride). Common drug interactions include pancreatitis among females and cardiomyopathy among males.

The phase IV clinical study analyzes what interactions people have when they take Viberzi and Bentyl. It is created by eHealthMe based on reports of 37 people who take the same drugs from the FDA, and is updated regularly.

What is Viberzi?

Viberzi has active ingredients of eluxadoline. eHealthMe is studying from 3,077 Viberzi users. Check the latest studies of Viberzi.

What is Bentyl?

Bentyl has active ingredients of dicyclomine hydrochloride. It is often used in irritable bowel syndrome. eHealthMe is studying from 10,754 Bentyl users. Check the latest studies of Bentyl.

On Jul, 19, 2026

37 people who take Viberzi and Bentyl together, and have interactions are studied.

What are the common drug interactions of Viberzi and Bentyl, by gender? *:

female:

Pancreatitis (inflammation of pancreas)
Constipation
Nausea (feeling of having an urge to vomit)
Pain
Sedation
Back pain
Chronic kidney disease
Fall
Head discomfort
Limb discomfort (discomfort in leg)

male:

Cardiomyopathy (weakening of the heart muscle)
Constipation
Rash
Suicidal ideation
Therapeutic response unexpected
Diverticulitis (digestive disease which involves the formation of pouches (diverticula) within the bowel wall)
Drug ineffective
Dyschezia (difficulty in defecating)
Feeling hot
Flushing (the warm, red condition of human skin)

What are the common drug interactions of Viberzi and Bentyl, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

Pancreatitis (inflammation of pancreas)

20-29:

Suicidal ideation

30-39:

Nausea (feeling of having an urge to vomit)
Feeling hot
Flushing (the warm, red condition of human skin)
Gastric disorder (disease of stomach)
Hyperhidrosis (abnormally increased sweating)
Neuralgia (pain in one or more nerves)
Pancreatitis (inflammation of pancreas)

40-49:

Back injury
Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
Cardiomyopathy (weakening of the heart muscle)
Lower respiratory tract infection
Nasopharyngitis (inflammation of the nasopharynx)
Pancreatitis acute (sudden inflammation of pancreas)
Pancreatitis chronic (chronic inflammation of pancreas)
Sinusitis (inflammation of sinus)

50-59:

Back pain
Nausea (feeling of having an urge to vomit)
Pancreatitis (inflammation of pancreas)
Abdominal pain upper
Constipation
Cough
Fall
Hospitalisation
Hyperhidrosis (abnormally increased sweating)
Malaise (a feeling of general discomfort or uneasiness)

60+:

Chronic kidney disease
Constipation
Metabolic encephalopathy (disorder or disease of the brain due to the body's disability to use energy)
Pancreatitis (inflammation of pancreas)
Psoriasis (immune-mediated disease that affects the skin)
Rash
Amylase increased
Diverticulitis (digestive disease which involves the formation of pouches (diverticula) within the bowel wall)
Dizziness
Dyschezia (difficulty in defecating)

What are the existing conditions these people have? *

Indigestion: 5 people, 13.51%
Diarrhea: 5 people, 13.51%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 4 people, 10.81%
Stress And Anxiety: 3 people, 8.11%
Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 3 people, 8.11%
Muscle Spasms (muscle contraction): 3 people, 8.11%
High Blood Pressure: 3 people, 8.11%
High Blood Cholesterol: 3 people, 8.11%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 3 people, 8.11%
Vitamin D Decreased: 2 people, 5.41%

* Approximation only. Some reports may have incomplete information.

Do you take Viberzi and Bentyl?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously